Pantecta (Pantoprazole)

Pantoprazole, the active ingredient in Pantecta, is a proton pump inhibitor presented as a oral dosage form for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease and is prescribed for adults and children who require reduction of gastric acid secretion.

GNH USA supplies Pantecta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is used to manage conditions that involve excess stomach acid production. - Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of the oesophageal lining. - Erosive esophagitis: accelerates ulcer healing and prevents recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumours. - Prevention of NSAID‑induced gastric ulcers: lowers ulcer risk in patients receiving long‑term non‑steroidal anti‑inflammatory drugs.

Adverse reactions to pantoprazole may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools without blood. - Nausea: feeling of stomach upset. - Abdominal pain: cramping or discomfort. - Flatulence: excess gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Liver enzyme elevation: abnormal liver function tests. - Fracture risk: increased incidence of hip, wrist or spine fractures with long‑term use.

When prescribing pantoprazole, clinicians should consider several safety aspects. - Assess renal and hepatic function: dose adjustment may be needed in impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor for infection: prolonged acid suppression can increase risk of gastrointestinal infections. - Evaluate bone health: long‑term therapy may affect calcium absorption. - Counsel on appropriate use: avoid unnecessary prolonged therapy. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Antifungal azoles (ketoconazole, itraconazole): reduced absorption and efficacy. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely): - Clopidogrel: possible reduction in antiplatelet effect. - Warfarin: potential alteration of INR values. - Methotrexate: increased systemic exposure at high doses. - Digoxin: modest increase in serum levels. - Iron supplements: decreased iron absorption when taken simultaneously.